Related references
Note: Only part of the references are listed.The wide-ranging phenotypes of ergosterol biosynthesis mutants, and implications for microbial cell factories
Emily J. Johnston et al.
YEAST (2020)
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
Arijit Bhattacharya et al.
GENES (2020)
Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites
Andrew W. Pountain et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
Jill Adler-Moore et al.
CLINICAL INFECTIOUS DISEASES (2019)
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
Alberto Rastrojo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
Roy Mwenechanya et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms
Christopher Fernandez-Prada et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Nontoxic antimicrobials that evade drug resistance
Stephen A. Davis et al.
NATURE CHEMICAL BIOLOGY (2015)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
C2′-OH of Amphotericin B Plays an Important Role in Binding the Primary Sterol of Human Cells but Not Yeast Cells
Brandon C. Wilcock et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania
Angana Mukherjee et al.
MOLECULAR MICROBIOLOGY (2013)
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Benjamin Matteson Vincent et al.
PLOS BIOLOGY (2013)
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Bidyut Purkait et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis
Abeer H. A. Mohamed Ahmed et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Amphotericin primarily kills yeast by simply binding ergosterol
Kaitlyn C. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing
Adriano C. Coelho et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Tim Downing et al.
GENOME RESEARCH (2011)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Parasite Susceptibility to Amphotericin B in Failures of Treatment for Visceral Leishmaniasis in Patients Coinfected with HIV Type 1 and Leishmania infantum
Laurence Lachaud et al.
CLINICAL INFECTIOUS DISEASES (2009)
Developmental regulation of gene expression in trypanosomatid parasitic protozoa
Simon Haile et al.
CURRENT OPINION IN MICROBIOLOGY (2007)
Amphotericin B treatment for Indian visceral leishmaniasis: Response to 15 daily versus alternate-day infusions
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Cloning of S-adenosyl-L-Methionine:: C-24-Δ-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-resistant promastigotes
M Pourshafie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination
B Papadopoulou et al.
INFECTION AND IMMUNITY (2002)
Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani
M Wiesgigl et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening
D Sereno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
